Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Guo Rong Zou"'
Publikováno v:
Journal of Thoracic Disease. 15:1838-1847
Publikováno v:
Eurasian Journal of Medicine & Oncology; 2024, Vol. 8 Issue 1, p24-31, 8p
Publikováno v:
Journal of Cancer
Background: Weekly and triweekly cisplatin-based concurrent chemoradiotherapy (CCRT) have been used in the treatment of nasopharyngeal carcinoma (NPC). Objective: This study aimed to compare the benefits and risks between the two treatments. Methods:
Publikováno v:
Journal of Cancer
Background: First degree family history of cancer is associated with developing esophageal cancer and sparse data is about the impact on poor survival among established esophageal squamous cell cancer (ESCC) patients. In this study, we investigated t
Publikováno v:
Therapeutics and Clinical Risk Management
Zhen Su,1,* Guo-rong Zou,1,* Jie Tang,1 Xiu Yue Li,1 Fang-Yun Xie2 1Panyu Central Hospital, Cancer Institute of Panyu, Guangzhou, People’s Republic of China; 2Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, State Key Laborat
Publikováno v:
Zhen ci yan jiu = Acupuncture research. 45(2)
To observe the effect of electroacupuncture (EA) preconditioning on the expression of liver protein kinase 1 (LKB1), adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) and 6-phosphofructo-2-kinase (PFK2) in cardiomyocytes of rats with a
Publikováno v:
Head & Neck. 41
Background Metastases to the bones, lungs, and liver are common in patients with nasopharyngeal carcinoma (NPC) but not to the brain and frontal bone (B + FB). Methods We describe a patient with NPC with B + FB metastasis. He received two cycles of p
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 28(3)
Clinical trials on docetaxel plus cisplatin (DDP) (TP regimen) in treating nasopharyngeal carcinoma (NPC) are still uncertain due to limited samples. This study was to compare the short-term efficacy and toxicity of induction chemotherapy with TP reg
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 26(8)
Docetaxel and cisplatin (DDP) are effective drugs for head and neck tumors. Stage II-III clinical trial of TP regimen (docetaxel combined DDP) for head and neck tumors has completed. This study was to compare the efficacy and toxicity of TP regimen a
Autor:
Guo-Rong, Zou, Yu-Jing, Zhang, Fang-Yun, Xie, Wei, Zheng, Hui-Xin, Li, Yun-Fei, Xia, Tong-Yu, Lin, Tai-Xiang, Lu
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 25(12)
Nasopharynx is a commonly involved site of non-Hodgkin's lymphoma (NHL), but the differences of clinical characteristics, prognosis, and treatment strategy between B-cell and NK/T-cell nasopharyngeal NHL have seldom been reported. This study was to i